Posts Tagged ‘biotech’
A new phase in Pentasweet’s €65 million investment – foundations laid for Europe’s first sweet protein production facility
One of the largest biotechnology investments in Lithuania in recent years is gaining momentum – the construction of Pentasweet’s €65 million brazzein sweet protein factory. This major national investment project has entered a new stage: a symbolic capsule has been placed into the foundations of the future factory at the Vilnius City Innovation Industrial Park. The factory is expected to begin operations in the first half of 2027.
“Lithuania is consistently strengthening its high value-added economy and is capable not only of creating innovation but also of turning it into real projects. The Pentasweet factory is the first brazzein production center of its kind in Europe, demonstrating that Lithuania can be among global leaders in life sciences. This is a meaningful investment not only in the economy but also in people’s health. Solutions that enable reduced sugar consumption have great potential to transform the food industry and everyday habits”: Inga Ruginienė, Prime Minister
Read full announcement (external link)
Originally published on 22 Apr
Read MoreEIB lends €100 million to Finnish company Orion Pharma for new cancer and pain treatments
The European Investment Bank (EIB) is lending €100 million to Finnish pharmaceutical company Orion Pharma to develop new treatments for cancer, pain and other serious conditions with few treatment options.
The financing will support Orion Pharma’s research and development activities across its European centres, covering personnel costs, clinical trials, patenting and investments in specialised laboratory equipment. By reinforcing Orion Pharma’s long-term R&D capacity, the EIB is helping strengthen Europe’s competitiveness in advanced biopharmaceutical innovation.
Read full announcement (external link)
Originally published on 15 Apr
Read MoreÄIO and tilk! debut the first commercial skincare product powered by breakthrough bio‑fermented RedOil
Estonian biotechnology company ÄIO and natural cosmetics brand tilk! announce the launch of their first commercial product together: Skin Booster Bio‑Fermented Serum with ÄIO RedOil.
The product is a significant step for ÄIO, marking its evolution from research and ingredient development to market-ready, consumer-facing applications. Developed by tilk!, the serum combines ÄIO’s RedOil with marine and plant-based actives to deliver a high-performance skincare solution grounded in both science and nature. The partnership marks a breakthrough for Estonia’s rising biotech and cosmetics sectors, demonstrating how local innovation can shape the future of clean, high‑performance beauty.
Read full announcement (external link)
Originally published on 7 Apr
Read More26 research projects funded in BioPhoT second call
The 26 highest ranked projects in the second BioPhoT call for research and innovation projects will receive funding. They will receive an investment of €4,710,859, with each project receiving up to €190,000 in funding for eight months of research and innovation activities.
Most of the supported projects – seven – will be carried out by research groups from the Institute of Solid State Physics at the University of Latvia. The University of Latvia follows with five supported projects, followed by the Institute of Organic Synthesis and Riga Technical University with four each. Two projects each will be implemented by teams from the Latvian Biomedical Research and Study Centre and Riga Stradins University, and one each by research groups from the Institute of Electronics and Computer Science and Ventspils University College.
Read full announcement (external link)
Originally published on 6 Mar
Read More